Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1992
DOI: 10.1253/jcj.56.620
|View full text |Cite
|
Sign up to set email alerts
|

High-energy Phosphate Metabolism of the Myocardium in Normal Subjects and Patients with Various Cardiomyopathies. The study using ECG gated MR spectroscopy with a localization technique.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

1996
1996
2016
2016

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(13 citation statements)
references
References 13 publications
0
13
0
Order By: Relevance
“…This pacing-gated 31 P NMR method may be useful for evaluating the efficiency of energy Circulation Journal Vol.66, January 2002 utilization of the myocardium in patients with ischemic heart disease, cardiac failure, and various cardiomyopathy. 27,28 …”
Section: Discussionmentioning
confidence: 99%
“…This pacing-gated 31 P NMR method may be useful for evaluating the efficiency of energy Circulation Journal Vol.66, January 2002 utilization of the myocardium in patients with ischemic heart disease, cardiac failure, and various cardiomyopathy. 27,28 …”
Section: Discussionmentioning
confidence: 99%
“…39 Because CK is relatively abundant even in the failing heart, 25,28 -32,38,40 a lower total creatine pool means that [PCr] must also be lower. 31 P NMR studies in the early 1990s by several groups [41][42][43][44] showed that [PCr]/[ATP] is lower in dilated cardiomyopathy and heart failure. In Figure 2, typical 31 P NMR spectra obtained noninvasively from normal and failing human hearts illustrate the changes in [ATP] and [PCr] that characterize the failing heart.…”
Section: Pcr and The Failing Heartmentioning
confidence: 99%
“…Some workers (34,52) report that the primary hypertrophic cardiomyopathy is more likely to result in an energy decline than the secondary hypertrophy, such as hypertension-induced LVH. In addition, a coexisting heart failure seems to increase the incidence of HEP abnormalities (21,47).…”
Section: Hypertrophic Model and Its Baseline Physiology/metabolismmentioning
confidence: 99%